SAMUEL MCELROY: Open Payments
NPI 1023302544 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 9 payments from 6 companies in 2025. Trend: 2023 $80 · 2024 $18 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $60 |
| Amgen Inc. | 2 | $52 |
| Eisai Inc. | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: Veozah, REPATHA, Leqembi, TZIELD, WATCHMAN FLX, LEQVIO, OTEZLA.
Industry payments across GA — which companies pay providers there.
